Stock In Focus – TAM Stock Screener – Co-Diagnostics Inc (NASDAQ: CODX)
Thursday, November 25, 2021 · Johnny Hopkins
As part of our ongoing series here at The Acquirer’s Multiple, we provide this feature article titled ‘Stock in Focus‘ where we focus on one of the stocks from our Stock Screeners.
One of the cheapest stocks in our Stock Screeners is:
Co-Diagnostics Inc (NASDAQ: CODX)
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI’s low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company’s diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
A quick look at the share price history for Co-Diagnostics Inc (below) over the past twelve months shows that the price is down 16%. Here’s why the company remains undervalued.
Summary
Market Cap: $263 Million
Enterprise Value: $190 Million
Operating Earnings
Operating Earnings: $50 Million
Acquirer’s Multiple
Acquirer’s Multiple: 3.79
Free Cash Flow (TTM)
Free Cash Flow: $55 Million
FCF/EV Yield
FCF/EV Yield: 29%
Other Indicators
Piotroski F-Score: 5
Altman Z-Score: 34.64
Beneish M-Score: -2.81
Shareholder Yield
Shareholder Yield: 27%